The cheaper of the two rival macular degeneration treatments could lead to blindness or other adverse events, new research determined.
Daily doses of aspirin in elderly adults can double the risk for developing the "wet" version of age-related macular degeneration (AMD), according to a new study.
Injections of the cancer drug Avastin, which is also a treatment for the wet form of age-related macular degeneration, has been linked to reports of blindness.
